Editorial
ASO Author Reflections: Does Nodal Disease Alone Warrant Adjuvant Radiotherapy after Pancreaticoduodenectomy?
Annals of surgical oncology
21 Apr 2026
PMID: 42012739
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
Although the benefits of perioperative chemotherapy for pancreatic ductal adenocarcinoma (PDAC) are well established, the role of adjuvant radiotherapy (adjXRT) following pancreaticoduodenectomy (PD) remains controversial. While the NCCN provides guidance regarding the use of adjXRT based on margin status, there is conflicting evidence supporting its role in nodal disease (N+) alone. [1st paragraph]
Metrics
2 Record Views
Details
- Title
- ASO Author Reflections: Does Nodal Disease Alone Warrant Adjuvant Radiotherapy after Pancreaticoduodenectomy?
- Creators
- Muhammad Muntazir Mehdi Khan - Allegheny Health NetworkCasey J. Allen - Drexel University, Surgery
- Publication Details
- Annals of surgical oncology
- Publisher
- Springer Nature
- Number of pages
- 1
- Resource Type
- Editorial
- Language
- English
- Academic Unit
- Surgery
- Web of Science ID
- WOS:001745372600001
- Scopus ID
- 2-s2.0-105036486908
- Other Identifier
- 991022181972104721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
Source: SDGs in the Output
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Collaboration types
- Domestic collaboration
- Web of Science research areas
- Oncology
- Surgery